The majority of Dravet syndrome patients have a loss-of-function mutation in SCN1A, the gene that encodes the voltage-gated sodium channel Nav1.1 (Meisler et al. 2010; Yamakawa 2009). The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.